한약을 사용한 암환자 대상 임상시험에서의 항암 효능 평가변수 고찰
A Review of Anticancer Efficacy Outcome Measures in Clinical Trials of Herbal Medicine for Cancer Patients
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives : The objective of this review is to examine the variety of evaluation parameters utilized in clinical trials that assess the anticancer efficacy of herbal medicine, focusing on the importance of including both symptomatic management and direct anticancer effectiveness. Methods : A detailed literature review was conducted across PubMed, Embase, and the Cochrane Library to identify clinical trials investigating the antitumor efficacy of herbal medicine. The search was performed on February 22, 2024. This review specifically examined the employed outcome measures, which were then categorized and analyzed to understand their relevance and application in evaluating the anticancer properties of herbal medicine. Results : From an initial search of 900 records, 15 clinical trials were selected for in-depth analysis after deduplication and screening. These studies evaluated the efficacy of herbal medicine across various cancers, including hepatocellular carcinoma, colorectal cancer, and breast cancer, using outcome measures such as survival rates, disease control rates, and quality of life improvements. The research spanned multiple countries, primarily in East Asia and the United States, reflecting a global interest in herbal medicine as a complementary approach to cancer treatment. The present study demonstrated that herbal medicine, especially when used alongside standard treatments, potentially improved clinical outcomes and patient well-being. Conclusions : The findings of this review highlight the need for a broader focus on the full range of therapeutic capabilities of herbal medicine, including its direct anticancer effects, in the management of cancer patients. Future oncology research involving herbal medicine should integrate a wide spectrum of clinical endpoints to fully ascertain its impact on cancer treatment and patient health.
Abstract
Objectives : The objective of this review is to examine the variety of evaluation parameters utilized in clinical trials that assess the anticancer efficacy of herbal medicine, focusing on the importance of including both symptomatic management and direct anticancer effectiveness. Methods : A detailed literature review was conducted across PubMed, Embase, and the Cochrane Library to identify clinical trials investigating the antitumor efficacy of herbal medicine. The search was performed on February 22, 2024. This review specifically examined the employed outcome measures, which were then categorized and analyzed to understand their relevance and application in evaluating the anticancer properties of herbal medicine. Results : From an initial search of 900 records, 15 clinical trials were selected for in-depth analysis after deduplication and screening. These studies evaluated the efficacy of herbal medicine across various cancers, including hepatocellular carcinoma, colorectal cancer, and breast cancer, using outcome measures such as survival rates, disease control rates, and quality of life improvements. The research spanned multiple countries, primarily in East Asia and the United States, reflecting a global interest in herbal medicine as a complementary approach to cancer treatment. The present study demonstrated that herbal medicine, especially when used alongside standard treatments, potentially improved clinical outcomes and patient well-being. Conclusions : The findings of this review highlight the need for a broader focus on the full range of therapeutic capabilities of herbal medicine, including its direct anticancer effects, in the management of cancer patients. Future oncology research involving herbal medicine should integrate a wide spectrum of clinical endpoints to fully ascertain its impact on cancer treatment and patient health.
참고문헌 (27)
- Ferlay J, "Cancer statistics for the year 2020: An overview", Int J Cancer (2021)
- Sung H, "Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36Cancers in 185 Countries", CA Cancer J Clin, 71(3), pp.209~249 (2021)
- Han Y, "The Role of Natural Products in the Improvement of Cancer-Associated Cachexia", Int J Mol Sci, 24(10) (2023)
- Yin SY, "Therapeutic applications of herbal medicines for cancer patients", Evid Based Complement Alternat Med, 2013, pp.302426~ (2013)
- Huang G, "System analysis of Huang-Lian-Jie-Du-Tang and their key active ingredients for overcoming CML resistance by suppression of leukemia stem cells", Phytomedicine, 117, pp.154918~ (2023)
- Jang S, "Characteristics of Herbal Medicine Users and Adverse Events Experienced in South Korea: A Survey Study", Evid Based Complement Alternat Med, 2017, pp.4089019~ (2017)
- Luo X, "Chinese Herbal Medicine for Functional Dyspepsia With Psychological Disorders : A Systematic Review and Meta-Analysis", Front Neurosci, 16, pp.933290~ (2022)
- Xu GZ, "Chinese herb"destagnation"series I : Combination of radiation with destagnation in the treatment of nasopharyngeal carcinoma(NPC) : a prospective randomized trial on 188 cases", Int J Radiat Oncol Biol Phys, 16(2), pp.297~300 (1989)
- Thompson LU, "Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer", Clin Cancer Res, 11(10), pp.3828~3835 (2005)
- Yang YF, "Randomized controlled study on effect of Quxie capsule on the median survival time and qualify of life in patients with advanced colorectal carcinoma", Zhongguo Zhong Xi Yi Jie He Za Zhi, 28(2), pp.111~114 (2008)
- Zhou LY, "Clinical observation on treatment of colonic cancer with combined treatment of chemotherapy and Chinese herbal medicine", Chin J Integr Med, 15(2), pp.107~111 (2009)
- Perez AT, "A phase 1B dose escalation trial of Scutellaria barbata(BZL101)for patients with metastatic breast cancer", Breast Cancer Res Treat, 120(1), pp.111~118 (2010)
- Saif MW, "Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies", Phytomedicine, 17(3-4), pp.161~169 (2010)
- Kummar S, "A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecanbased chemotherapy in patients with advanced colorectal cancer", Clin Colorectal Cancer, 10(2), pp.85~96 (2011)
- Xu ZY, "Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy", J Cancer Res Clin Oncol, 137(7), pp.1117~1122 (2011)
- Xu Y, "Survival benefit of traditional Chinese herbal medicine(a herbal formula for invigorating spleen)for patients with advanced gastric cancer", Integr Cancer Ther, 12(5), pp.414~422 (2013)
- Chen WT, "Effectiveness of a novel herbal agent MB-6 as a potential adjunct to 5-fluoracil-based chemotherapy in colorectal cancer", Nutr Res, 34(7), pp.585~594 (2014)
- Cheon C, "A Phase I Study to Evaluate the Safety of the Herbal Medicine SH003in Patients With Solid Cancer", Integr Cancer Ther, 19, pp.1534735420911442~ (2020)
- Jia R, "Effect of PRM1201 Combined With Adjuvant Chemotherapy on Preventing Recurrence and Metastasis of Stage III Colon Cancer : A Randomized, Double-Blind, Placebo-Controlled Clinical Trial", Front Oncol, 11, pp.618793~ (2021)
- Yang X, "Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT", CyclinD1, p27 pathway, pp.Phytomedicine, 2021[DOI]
- Changou CA, "A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma", Oncologist, 26(3), pp.e367~e373 (2021)
- Zhang T, "Efficacy of Quxie Capsule in Metastatic Colorectal Cancer : Long-Term Survival Update of A Double-Blind, Randomized, Placebo Controlled Trial", Chin J Integr Med, 28(11), pp.971~974 (2022)
- Lee JY, "Traditional Herbal Medicine, Sipjeondaebo-Tang, for Cancer-Related Fatigue : A Randomized, Placebo-Controlled, Preliminary Study", Integr Cancer Ther, 20, pp.15347354211040830~ (2021)
- Jo HG, "East Asian Herbal Medicine to Reduce Primary Pain and Adverse Events in Cancer Patients : A Systematic Review and Meta-Analysis With Association Rule Mining to Identify Core Herb Combination", Front Pharmacol, 12, pp.800571~ (2022)
- Hess LM, "Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology", J Cancer, 10(16), pp.3717~3727 (2019)
- Hricak H, "Oncologic Imaging", pp.2~13 (2007), W.B. Saunders
- Sznol M, "Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents : useful endpoint or hype?", Curr Opin Investig Drugs, 11(12), pp.1340~1341 (2010)